Stem cells shown to restore erection capability in men with erectile dysfunction

European Association of Urology 22 March 2017 New clinical trial results show that stem cells can restore sufficient erectile function to allow previously impotent men to have spontaneous intercourse. This is the first time stem cell therapy has produced patients who have recovered sufficient erectile function to enable intercourse. This is an early trial, which…

Article Citations

Nguyen A, Guo J, Banyard DA, Fadavi D, Toranto JD, Wirth GA, Paydar KZ, Evans GR, Widgerow AD. Stromal vascular fraction: A regenerative reality? Part 1: Current concepts and review of the literature. J Plast Reconstr Aesthet Surg. 2016 Feb;69(2):170-9. doi: 10.1016/j.bjps.2015.10.015. Epub 2015 Oct 31. Click here to purchase article   Guo J, Nguyen A, Banyard DA, Fadavi D, Toranto JD, Wirth GA, Paydar KZ, Evans GR, Widgerow AD. Stromal vascular fraction: A regenerative reality? Part 2: Mechanisms of regenerative action. J Plast Reconstr Aesthet Surg. 2016 Feb;69(2):180-8. doi:…

EFFECTS OF STEM CELL TREATMENT IN HUMAN PATIENTS WITH PEYRONIE DISEASE

Effects of Stem Cell Treatment in Human Patients With Peyronie Disease Jason A. Levy, OMS III, MS; Melissa Marchand, PA-C; Leanne Iorio, OMS I; Gilles Zribi; Michael P. Zahalsky, MD Author Notes The Journal of the American Osteopathic Association, October 2015, Vol. 115, e8-e13. doi:10.7556/jaoa.2015.124 Abstract Context: Peyronie disease (PD) is a connective tissue disorder…

Clinical outcome of autologous peripheral blood stem cell transplantation in opticospinal and conventional forms of secondary progressive multiple sclerosis in a Chinese population.

Xu J1, Ji BX, Su L, Dong HQ, Sun WL, Wan SG, Liu YO, Zhang P, Liu CY. Author information Abstract To evaluate clinical outcomes of autologous peripheral blood stem cell transplantation (APBCST) between opticospinal multiple sclerosis (OSMS) and conventional multiple sclerosis (CMS) during disease progressive stage in a Chinese population. Thirty-six secondary progressive MS patients, among whom 21 were with OSMS and 15 with…

Human umbilical cord mesenchymal stem cell therapy on neuromyelitis optica.

Lu Z1, Ye D, Qian L, Zhu L, Wang C, Guan D, Zhang X, Xu Y. Author information Abstract Stem cell transplantation is a promising therapy for neuromyelitis optica (NMO). Among stem cell varieties, human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) possess many advantages, add a differential potential into neural cells, secrete a set of trophic factors and cytokines, regulate immunological function, and have therapeutic potential for neurological…